SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Synta Pharmaceuticals
SNTA 0.343+26.6%Jul 22 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: HMS889/29/2007 5:20:10 AM
  Read Replies (1) of 112
 
If this company's pipeline is one tenth as good as its cast (BODs, scientists, managers and staff) then it could become big.

That cast is of course very expensive, and any deals made with larger pharma companies may require trimming or other cost containments as directed by new active partners.

There is a lot to like here in terms of a pure speculation.

Lest I remind myself, it is good to be cautious too - Long-Term Capital Management had one of the finest capital crews ever assembled, and that boat of laureates almost sank an entire armada of banks.

I might consider a starter position around 5 or 6 US.

Welcome any comments, especially any hard-to-find pointers or facts.

Thanks,
Andrew
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News